Friday 10 July 2015, Amsterdam
The report, now available on ASDReports “Urinalysis Market by Product (Dipstick, Reagent, Urine Analyzer, POC), Test Type (Biochemical, Sediment, Microscopic), Application (Diagnosis, Diabetes, UTI, Kidney Disease, Pregnancy), End User (Hospital, Research Institute, Home) - Forecast to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the urinalysis market along with the estimates and forecasts of the revenue and share analysis.
The report segments this market on the basis of products, test type, applications, end user, and geography. In the test type market, the biochemical urinalysis segment is expected to account for the largest share in 2014. The biochemical urinalysis is a cost effective and accurate method for diagnosing various types of diseases; this is a major reason for the high growth of this market. The sediment urinalysis segment is expected to grow at the highest CAGR from 2014 to 2019, due to the technological advancements and launch of new and advanced products in the market.
Based on geography, the global urinalysis market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2014. The growth of this market is driven by factors such as increasing number of prognostic urinalysis tests, implementation of affordable care act in the U.S., and rising incidences of diabetes in the region.
Key players in the urinalysis market include Alere Inc. (Acon Labs) (U.S.), ARKRAY Inc. (Japan), Bio-Rad (U.S.), Danaher (Iris International) (U.S.), E77 Eletronika (Hungary), Mindray (China), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Sysmex (Japan), and Urit Medical (China) amongst others.
Publish date : March 2015
Report code : ASDR-208178
Pages : 220